Neurohypophyseal Diabetes InsipidusSymptoms, Doctors, Treatments, Advances & More
Learn About Neurohypophyseal Diabetes Insipidus
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Reading Hospital Endocrinology & Diabetes Center Wyomissing
Ilan Gabriely is an Internal Medicine specialist and an Endocrinologist practicing medicine in Wyomissing, Pennsylvania. Dr. Gabriely is rated as a Distinguished provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Hyperparathyroidism, Thyroid Cancer, and Anaplastic Thyroid Cancer. Dr. Gabriely is board certified in American Board Of Internal Medicine.
Diabetes And Endocrinology Center At Specialty Services Pavilion
Andjela Drincic is an Endocrinologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 36 years. Dr. Drincic is rated as an Advanced provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Pituitary Tumor, Hypogonadism, and Type 2 Diabetes (T2D).
Tower Health Medical Group Internal Medicine - Wyomissing 1st Floor
Tatyana Erlikh is a primary care provider, practicing in Internal Medicine in Wyomissing, Pennsylvania. Dr. Erlikh is rated as an Advanced provider by MediFind in the treatment of Neurohypophyseal Diabetes Insipidus. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Psoriasis, Psoriatic Arthritis, Hypertension, and Familial Hypertension. Dr. Erlikh is board certified in American Board Of Internal Medicine.
Summary: Central diabetes insipidus (CDI),a disease caused by the decrease of AVP (a hormone involved in the control of water-electrolyte balance ) secretion and characerized by polyuria, is a common complication after neurosurgerical intervention and there is a lack of diagnostic criteria.Since the surgry casuses damage to patients' AVP-secreting neuronal cells, transient CDI (t-CDI) usually occurs 24-48h...
Summary: This randomized, placebo-controlled, double-blind trial aims to investigate intranasal OXT as a novel therapeutical option in central diabetes insipidus (cDI) to improve psychological symptoms and socio-emotional functioning. Optionally, patients can present for additional assessments in sub-studies: * fMRI sub-study at day 14 (± 2 days) (one additional visit) * Social-stress sub-study at day 14 (...